Novartis Cosentyx® receives FDA approval for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis
New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk…
Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion